Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrazoloacridine in Metastatic Breast Cancer
NCT00003041Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jul 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrazoloacridine in breast cancer, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Jul 1997; status: completed.
02
Drugs
pyrazoloacridine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003041.